Lantheus Holdings’ activist position in Perspective Therapeutics fell to 10.0%, representing 11,440,513 shares of Common Stock. The group’s stated authority to sell shares under certain market conditions matters because its ownership can change through private, open-market, block, registered or other permitted transactions.

Key Highlights

  • Lantheus Alpha sold 78,145 shares on September 3, 2026, at an average price of $3.1058 per share.
  • Lantheus Holdings, Lantheus Medical Imaging and Lantheus Alpha share voting and dispositive power over the stake.
  • The 10.0% ownership calculation uses 114,151,663 Perspective Therapeutics shares outstanding as of August 5, 2026.

Perspective Therapeutics, Inc. (AMEX: CATX) now has Lantheus Holdings (NASDAQ: LNTH) as an activist holder of 10.0% of its Common Stock, equal to 11,440,513 shares. Lantheus Holdings, Lantheus Medical Imaging and Lantheus Alpha are the reporting persons connected with the position. The three entities may each be considered to share voting and dispositive power over the shares.

Lantheus Holds 10.0% Position

The reported 10.0% beneficial ownership is calculated against 114,151,663 shares of Perspective Therapeutics Common Stock outstanding as of August 5, 2026. The stake consists of 11,440,513 shares. Lantheus Alpha directly owns the Common Stock. Lantheus Medical owns Lantheus Alpha, and Lantheus Holdings owns Lantheus Medical. That structure gives each reporting person shared voting and dispositive power over the same position.

Four August And September Sales

Lantheus Alpha sold shares on four dates. The transactions covered 78,145 shares on August 31, 2026, at an average price of $3.143 per share; 35,769 shares on September 1, 2026, at $3.1193 per share; 42,129 shares on September 2, 2026, at $3.1147 per share; and 80,783 shares on September 3, 2026, at $3.1058 per share. The reported ownership as of September 3, 2026 reflects both dilution of the beneficial position since the original statement and these dispositions. The number of shares shown has been adjusted for Perspective Therapeutics’ 1-for-10 reverse stock split, which took effect on June 14, 2024.

Authority To Sell More Shares

Lantheus Holdings, Lantheus Medical and Lantheus Alpha are authorized to sell Common Stock from time to time, subject to certain market conditions. Lantheus Medical was added as an additional reporting person, and the three entities share the same principal office at 201 Burlington Road, South Building, Bedford, Massachusetts 01730.